Joshua Lowinsky
Psychiatry · Indianapolis, INNPI 1689625493
Payments from drug & device makers
Across 212 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$910
- Teva Pharmaceuticals USA, Inc.$380
- AbbVie$354
- Vanda Pharmaceuticals Inc.$353
- Axsome Therapeutics, Inc.$256
- Corium, LLC$206
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,78399%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 69 | $910 |
| Teva Pharmaceuticals USA, Inc. | 14 | $380 |
| AbbVie(2 entities) | 17 | $354 |
| Vanda Pharmaceuticals Inc. | 15 | $353 |
| Axsome Therapeutics, Inc. | 12 | $256 |
| Corium, LLC | 12 | $206 |
| Lundbeck LLC | 10 | $163 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $151 |
| Otsuka America Pharmaceutical, Inc. | 9 | $150 |
| Johnson & Johnson | 7 | $141 |
| Noven Therapeutics, LLC | 6 | $129 |
| Ironshore Pharmaceuticals Inc. | 6 | $93 |
| Neos Therapeutics, LP | 4 | $91 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $88 |
| Collegium Pharmaceutical, Inc. | 3 | $48 |
| Tris Pharma Inc | 3 | $46 |
| Vertical Pharmaceuticals, LLC | 3 | $43 |
| Neurocrine Biosciences, Inc. | 2 | $42 |
| Adlon Therapeutics L.p. | 2 | $31 |
| Neuronetics, Inc. | 1 | $25 |
| Shire North American Group Inc | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| OWP Pharmaceuticals, Inc. | 1 | $20 |
| Rhodes Pharmaceuticals L.p. | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,814 in reported general payments places this provider in the 80th percentile of 514 psychiatry providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 12 | $15,797 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $5,223 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 25 | $2,771 |
| Clozapine | 45 | $1,875 |
| Olanzapine | 15 | $1,629 |
| Ziprasidone Hcl | 21 | $1,420 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $795 |
| Lamotrigine | 38 | $724 |
| Bupropion XlBupropion Hcl | 27 | $661 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $515 |
| Clonazepam | 35 | $469 |
| Fluoxetine Hcl | 32 | $299 |
| Trazodone Hcl | 22 | $289 |
| Alprazolam | 24 | $272 |
| Doxepin Hcl | 12 | $228 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $354 | $15,79712 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $151 | $5,22311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 514 psychiatry providers in Indiana.
Other psychiatry in Indianapolis
- Anantha ShekharIndianapolis$433K
- Leslie HulvershornIndianapolis$159K
- Charles BeasleyIndianapolis$129K
- Alan BreierIndianapolis$114K
- John NurnbergerIndianapolis$104K
- Susan ConroyIndianapolis$73K
- Dmitry ArbuckIndianapolis$40K
- Michael FrancisIndianapolis$26K
- Albert AllenIndianapolis$24K
- Jerad DaltonIndianapolis$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.